Moos, Roger von: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

Roger von Moos, David Henry, Saroj Vadhan-Raj, Vania Hungria, Andrew Spencer, Vera Hirsh, Jianming Wang, Jun Susie, Yeh Howard, Roger Dansey

Journal:

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

2

The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease

Diel, Ingo J., Body, Jean-Jacques, Stopeck, Alison T., Vadhan-Raj, Saroj, Spencer, Andrew, Steger, Günther, von Moos, Roger, Goldwasser, François, Feng, Amy, Braun, Ada

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 703 KB

english, 2015

3

Phase I trial of the androgen receptor modulator CR1447 in breast cancer

Zweifel, Martin, Thuerlimann, Beat, Riniker, Salome, Weder, Patrik, von Moos, Roger, Pagani, Olivia, Bigler, Martin, Rothgiesser, Karin M, Pilop, Christiane, Hawle, Hanne, Brauchli, Peter, Tapia, Coya

Journal:

Endocrine Connections

Year:

2017

Language:

english

File:

PDF, 1.06 MB

english, 2017

4

A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors

de Weger, Vincent A., Goel, Sanjay, von Moos, Roger, Schellens, Jan H. M., Mach, Nicholas, Tan, Eugene, Anand, Suraj, Scott, Jeffrey W., Lassen, Ulrik

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2017

Language:

english

File:

PDF, 657 KB

english, 2017

5

Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation

Ying Waeckerle-Men, Edith Uetz-von Allmen, Roger von Moos, Brendan J. Classon, Elke Scandella, Hans-Peter Schmid, Burkhard Ludewig, Marcus Groettrup, Silke Gillessen

Journal:

Year:

2005

Language:

english

File:

PDF, 464 KB

english, 2005

6

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

Ying Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, Roger von Moos, Christel Böhme, Hans-Peter Schmid, Daniel Ackermann, Thomas Cerny, Burkhard Ludewig, Marcus Groettrup, Silke Gillessen

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 518 KB

english, 2006

7

Metastatic bone pain: treatment options with an emphasis on bisphosphonates

Roger von Moos, Florian Strasser, Silke Gillessen, Kathrin Zaugg

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 225 KB

english, 2008

8

Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

Karin Ribi, Dieter Koeberle, Jan C. Schuller, Hanspeter Honegger, Arnaud Roth, Viviane Hess, Peter Moosmann, Roger von Moos, Markus Borner, Norbert Lombriser, Bernhard Pestalozzi, Thomas Ruhstaller

Journal:

Supportive Care in Cancer

Year:

2009

Language:

english

File:

PDF, 182 KB

english, 2009

9

Heated (37°C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?

Richard Cathomas, Dieter Köberle, Thomas Ruhstaller, Gisela Mayer, Andrea Räss, Ulrich Mey, Roger von Moos

Journal:

Supportive Care in Cancer

Year:

2010

Language:

english

File:

PDF, 151 KB

english, 2010

10

Pain outcomes in patients with advanced breast cancer and bone metastases : Results from a randomized, double-blind study of denosumab and zoledronic acid

Charles S. Cleeland, Jean-Jacques Body, Alison Stopeck, Roger von Moos, Lesley Fallowfield, Susan D. Mathias, Donald L. Patrick, Mark Clemons, Katia Tonkin, Norikazu Masuda, Allan Lipton, Richard de B

Journal:

Year:

2012

Language:

english

File:

PDF, 346 KB

english, 2012

11

Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts

Roger von Moos, Beat J.K. Thuerlimann, Matti Aapro, Daniel Rayson, Karen Harrold, Jalid Sehouli, Florian Scotte, Domenica Lorusso, Reinhard Dummer, Mario E. Lacouture, Jürgen Lademann, Axel Hauschild

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 378 KB

english, 2008

12

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Xavier Pivot, Andreas Schneeweiss, Shailendra Verma, Christoph Thomssen, José Luis Passos-Coelho, Giovanni Benedetti, Eva Ciruelos, Roger von Moos, Hong-Tai Chang, Anja-Alexandra Duenne, David W. Mile

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 531 KB

english, 2011

13

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

Gianfranco A. Pesce, Dirk Klingbiel, Karin Ribi, Abderahim Zouhair, Roger von Moos, Marc Schlaeppi, Clemens B. Caspar, Natalie Fischer, Sandro Anchisi, Solange Peters, Richard Cathomas, Jürg Bernhard,

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 433 KB

english, 2012

14

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Jaafar Bennouna, Javier Sastre, Dirk Arnold, Pia Österlund, Richard Greil, Eric Van Cutsem, Roger von Moos, Jose Maria Viéitez, Olivier Bouché, Christophe Borg, Claus-Christoph Steffens, Vicente Alons

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 300 KB

english, 2013

15

Ibandronate provides efficacy and safety in the treatment of metastatic bone disease

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 197 KB

english, 2006

16

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

Zappa, Francesco, Droege, Cornelia, Betticher, Daniel, von Moos, Roger, Bubendorf, Lukas, Ochsenbein, Adrian, Gautschi, Oliver, Oppliger Leibundgut, Elisabeth, Froesch, Patrizia, Stahel, Rolf, Hess, T

Journal:

Year:

2012

Language:

english

File:

PDF, 325 KB

english, 2012

17

Trastuzumab Treatment beyond Progression in Advanced Breast Cancer: Patterns of Care in Six Swiss Breast Cancer Centers

Huober, Jens, Baumann, Michael, Rochlitz, Christoph, Aebi, Stefan, Güth, Uwe, von Moos, Roger, Müller, Andreas, von Rohr, Lukas, Widmer, Isabelle, Thürlimann, Beat

Journal:

Year:

2011

Language:

english

File:

PDF, 227 KB

english, 2011

18

Reducing the burden of bone metastases

Roger von Moos, Cora Sternberg, Jean-Jacques Body…

Journal:

Supportive Care in Cancer

Year:

2013

Language:

english

File:

PDF, 423 KB

english, 2013

19

What can we learn from the ZOOM trial?

Hayoz, Stefanie, Klingbiel, Dirk, Brauchli, Peter, Moos, Roger von

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 37 KB

english, 2013

20

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer

Pless, Miklos, Droege, Cornelia, von Moos, Roger, Salzberg, Marc, Betticher, Daniel

Journal:

Year:

2013

Language:

english

File:

PDF, 757 KB

english, 2013

21

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

von Moos, Roger, Body, Jean-Jacques, Egerdie, Blair, Stopeck, Alison, Brown, Janet E., Damyanov, Danail, Fallowfield, Lesley J., Marx, Gavin, Cleeland, Charles S., Patrick, Donald L., Palazzo, Felipe

Journal:

Supportive Care in Cancer

Year:

2014

Language:

english

File:

PDF, 149 KB

english, 2014

22

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

Hechmati, Guy, Hauber, A. Brett, Arellano, Jorge, Mohamed, Ateesha F., Qian, Yi, Gatta, Francesca, Haynes, Ian, Bahl, Amit, von Moos, Roger, Body, Jean-Jacques

Journal:

Supportive Care in Cancer

Year:

2015

Language:

english

File:

PDF, 355 KB

english, 2015

23

RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?

Cathomas, Richard, Rothermundt, Christian, Bode, Beata, Fuchs, Bruno, von Moos, Roger, Schwitter, Michael

Journal:

Year:

2015

Language:

english

File:

PDF, 162 KB

english, 2015

24

Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents

Patrick, Donald L., Cleeland, Charles S., von Moos, Roger, Fallowfield, Lesley, Wei, Rachel, Öhrling, Katarina, Qian, Yi

Journal:

Supportive Care in Cancer

Year:

2015

Language:

english

File:

PDF, 357 KB

english, 2015

25

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases

von Moos, Roger, Body, Jean-Jacques, Egerdie, Blair, Stopeck, Alison, Brown, Janet, Fallowfield, Lesley, Patrick, Donald L., Cleeland, Charles, Damyanov, Danail, Palazzo, Felipe Salvador, Marx, Gavin,

Journal:

Supportive Care in Cancer

Year:

2016

Language:

english

File:

PDF, 478 KB

english, 2016

26

Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience

Volk, Viktoria, Cathomas, Richard, Mark, Michael, von Moos, Roger, Klingbiel, Dirk, Brossart, Peter, Mey, Ulrich

Journal:

Supportive Care in Cancer

Year:

2016

Language:

english

File:

PDF, 604 KB

english, 2016

27

Self-Reported Compliance with Capecitabine: Findings from a Prospective Cohort Analysis

Winterhalder, Ralph, Hoesli, Pierre, Delmore, Geoffrey, Pederiva, Stefanie, Bressoud, Albéric, Hermann, Frank, von Moos, Roger

Journal:

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

28

Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer

Salzberg, Marc, Th&uuml, rlimann, Beat, Bonnefois, Herv&eacute, , Fink, Daniel, Rochlitz, Christoph, von Moos, Roger, Senn, Hansj&ouml, rg

Journal:

Year:

2005

Language:

english

File:

PDF, 122 KB

english, 2005

29

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study

Salzberg, Marc, Th&uuml, rlimann, Beat, Hasler, Ursula, Delmore, Geoffrey, von Rohr, Albert, Th&uuml, rlimann, Annatina, Ruhstaller, Thomas, Stopatschinskaja, Shanna, von Moos, Roger

Journal:

Year:

2007

Language:

english

File:

PDF, 112 KB

english, 2007

30

Fatal Herpes Simplex Virus Hepatitis in a Patient with Esophageal Cancer under Radiochemotherapy

Grimm, Birgit, Padberg, Barbara, Ruhstaller, Thomas, Fleisch, Felix, von Moos, Roger

Journal:

Year:

2008

Language:

english

File:

PDF, 247 KB

english, 2008

31

Breast Cancer Patients on Endocrine Therapy Reveal More Symptoms when Self-Reporting than in Pivotal Trials: An Outcome Research Study

Ruhstaller, Thomas, von Moos, Roger, Rufibach, Kaspar, Ribi, Karin, Glaus, Agnes, Spaeti, Bruno, Koeberle, Dieter, Mueller, Urs, Hoefliger, Markus, Hess, Dagmar, Boehme, Christel, Thuerlimann, Beat

Journal:

Year:

2009

Language:

english

File:

PDF, 145 KB

english, 2009

32

Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)

Ruhstaller, Thomas, Templeton, Arnoud, Ribi, Karin, Schuller, Jan C., Borner, Markus, Thierstein, Sandra, von Moos, Roger, Pederiva, Stefanie, Lohri, Andreas, Lombriser, Norbert, von Briel, Christian,

Journal:

Year:

2010

File:

PDF, 531 KB

2010

33

Intravascular Lymphoma Mimicking Cerebral Stroke: Report of Two Cases

Hundsberger, Thomas, Cogliatti, Sergio, Kleger, Gian-Reto, Fretz, Christian, Gähler, Anita, Anliker, Mark, Fournier, Jean-Yves, von Moos, Roger, Tettenborn, Barbara, Driessen, Christoph

Journal:

Case Reports in Neurology

Year:

2011

Language:

english

File:

PDF, 4.32 MB

english, 2011

34

Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques

Schoenewolf, Nicola L., Dummer, Reinhard, Mihic-Probst, Daniela, Moch, Holger, Simcock, Mathew, Ochsenbein, Adrian, Gillessen, Silke, Schraml, Peter, von Moos, Roger

Journal:

Case Reports in Oncology

Year:

2012

Language:

english

File:

PDF, 958 KB

english, 2012

35

Minimal Change Glomerulonephritis in Chronic Lymphocytic Leukemia: Pathophysiological and Therapeutic Aspects

Alzamora, Meritxell Garcia, Schmidli, Markus, Hess, Urs, Cathomas, Richard, Moos, Roger von

Journal:

Year:

2006

File:

PDF, 48 KB

2006

36

Successful Treatment of Acute Disseminated Intravascular Coagulation in a Patient with Metastatic Melanoma

Schlaeppi, Marc Roger, Korte, Wolfgang, Moos, Roger von, Cerny, Thomas, Gillessen, Silke

Journal:

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

37

Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03)

von Moos, Roger, Roth, Arnaud, Ruhstaller, Thomas, Widmer, Lucas, Uhlmann, Catrina, Cathomas, Richard, Köberle, Dieter, Simcock, Mathew, Lanz, Doris, Popescu, Razvan

Journal:

Year:

2010

Language:

english

File:

PDF, 122 KB

english, 2010

38

Long-Term Renal Safety Profile of Ibandronate 6 mg Infused over 15 Minutes

von Moos, Roger, Caspar, Clemens B., Steiner, Rolf, Angst, Rahel, Inauen, Roman, Schmieding, Kerstin, Thürlimann, Beat

Journal:

Year:

2010

File:

PDF, 208 KB

2010

39

Spontaneous Pneumothorax During Chemotherapy: A Case Report

Fehr, Martin, von Moos, Roger, Furrer, Markus, Cathomas, Richard

Journal:

Year:

2010

Language:

english

File:

PDF, 568 KB

english, 2010

40

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies

Gallerani, Elisa, Cathomas, Richard, Sessa, Cristiana, Digena, Tiziana, Bartosek, Anna Amalia, Zotto, Laura Dal, von Moos, Roger

Journal:

Year:

2013

Language:

english

File:

PDF, 321 KB

english, 2013

41

Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer

Cleeland, Charles, von Moos, Roger, Walker, Mark S., Wang, Yuanyuan, Gao, Jianqing, Chavez-MacGregor, Mariana, Liede, Alexander, Arellano, Jorge, Balakumaran, Arun, Qian, Yi

Journal:

Supportive Care in Cancer

Year:

2016

Language:

english

File:

PDF, 539 KB

english, 2016

42

Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)

Matter-Walstra, Klazien, Schwenkglenks, Matthias, Betticher, Daniel, von Moos, Roger, Dietrich, Daniel, Baertschi, Daniela, Koeberle, Dieter

Journal:

Clinical Colorectal Cancer

Year:

2016

Language:

english

File:

PDF, 644 KB

english, 2016

43

Sarcoidosis Induced by Interferon-α in Melanoma Patients

Heinzerling, Lucie M., Anliker, Mark D., Müller, Joachim, Schlaeppi, Marc, von Moos, Roger

Journal:

Journal of Immunotherapy

Year:

2010

Language:

english

File:

PDF, 207 KB

english, 2010

44

Intratumoral Therapy With Interferon-α in a Locoregional Advanced Malignant Blue Nevus

Moos, Roger von, Schaffner, Reto, Cathomas, Richard, Grimm, Birgit

Journal:

Journal of Immunotherapy

Year:

2010

Language:

english

File:

PDF, 402 KB

english, 2010

45

Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases

Metaxas, Yannis, Cathomas, Richard, Mark, Michael, von Moos, Roger

Journal:

Year:

2016

Language:

english

File:

PDF, 474 KB

english, 2016

46

Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation

Mey, Ulrich J.M., Renner, Christoph, von Moos, Roger

Journal:

Hematological Oncology

Year:

2016

Language:

english

File:

PDF, 133 KB

english, 2016

47

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries

Body, Jean-Jacques, Acklin, Yves Pascal, Gunther, Oliver, Hechmati, Guy, Pereira, João, Maniadakis, Nikos, Terpos, Evangelos, Finek, Jindrich, von Moos, Roger, Talbot, Susan, Sleeboom, Harm

Journal:

Journal of Bone Oncology

Year:

2016

Language:

english

File:

PDF, 425 KB

english, 2016

48

Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome

Hess, Viviane, Winterhalder, Ralph, von Moos, Roger, Widmer, Lucas, Stocker, Priska, Jermann, Monika, Herrmann, Richard, Koeberle, Dieter

Journal:

Clinical Colorectal Cancer

Year:

2016

Language:

english

File:

PDF, 444 KB

english, 2016

49

Severe Hyponatremia in a Patient with Mantle Cell Lymphoma Treated with Bortezomib: A Case Report and Review of the Literature

Brodmann, Stefan, Klaas, Evelyne Gyr, Cathomas, Richard, Girardi, Vincenzo, von Moos, Roger

Journal:

Year:

2007

Language:

english

File:

PDF, 56 KB

english, 2007

50

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

von Moos, Roger

Journal:

Oncology Reports

Year:

2012

Language:

english

File:

PDF, 397 KB

english, 2012